Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out

Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out

Abstract Background Oral daily preexposure prophylaxis (PrEP) using emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) is recommended as standard of care for prevention in individuals at high risk for HIV infection, including pregnant and postpartum cisgender women. FTC/TDF is also active again...

Full description

Bibliographic Details
Main Authors: Dvora Joseph Davey, Nei-yuan Hsiao, C. Wendy Spearman, Mark Sonderup, Nai-Chung Hu, Nyiko Mashele, Rufaro Mvududu, Landon Myer
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Infectious Diseases
Subjects:
Pre-exposure prophylaxis
Pregnant
Hepatitis B
HIV
Online Access:https://doi.org/10.1186/s12879-022-07697-5

Internet

https://doi.org/10.1186/s12879-022-07697-5

Similar Items